Behçet Uveitis

REFERENCES

• Zierhut M, Abu El-Asrar AM, Bodaghi B, Tugal-Tutkun I. Therapy of ocular Behçet disease. Ocul Immunol Inflamm. 2014;22(1):64–76.
   PubMed Web of Science ®Google Scholar
• Mesquida M, Molins B, Llorenç V, Hernández MV, Espinosa G, Dick AD, Adán A. Current and future treatments for Behçet’s uveitis: road to remission. Int Ophthalmol. 2014;34(2):365–381.
   PubMed Web of Science ®Google Scholar
• Tugal-Tutkun I, Gupta V, Cunningham ET Jr. Differential diagnosis of Behçet uveitis. Ocul Immunol Inflamm. 2013;21(5):337–350.
   PubMed Web of Science ®Google Scholar
• Tugal-Tutkun I. Imaging in the diagnosis and management of Behçet disease. Int Ophthalmol Clin. 2012;52(4):183–190.
   PubMedGoogle Scholar
• Cingu AK, Onal S, Urgancioglu M, Tugal-Tutkun I. Comparison of presenting features and three-year disease course in Turkish patients with Behçet uveitis who presented in the early 1990s and the early 2000s. Ocul Immunol Inflamm. 2012;20(6):423–428.
   PubMed Web of Science ®Google Scholar
• Tugal-Tutkun I, Onal S, Altan-Yaycioglu R, Huseyin Altunbas H, Urgancioglu M. Uveitis in Behçet disease: an analysis of 880 patients. Am J Ophthalmol. 2004;138(3):373–380.
   PubMed Web of Science ®Google Scholar
• Vallet H, Riviere S, Sanna A, Deroux A, Moulis G, Addimanda O, Salvarani C, Lambert M, Bielefeld P, Seve P, Sibilia J, Pasquali J, Fraison J, Marie I, Perard L, Bouillet L, Cohen F, Sene D, Schoindre Y, Lidove O, Le Hoang P, Hachulla E, Fain O, Mariette X, Papo T, Wechsler B, Bodaghi B, Rigon MR, Cacoub P, Saadoun D; French Behçet Network. Efficacy of anti-TNF alpha in severe and/or refractory Behçet’s disease: Multicenter study of 124 patients. J Autoimmun. 2015;62:67–74.
   PubMed Web of Science ®Google Scholar
• Levy-Clarke G, Jabs DA, Read RW, Rosenbaum JT, Vitale A, Van Gelder RN. Expert panel recommendations for the use of anti-tumor necrosis factor biologic agents in patients with ocular inflammatory disorders. Ophthalmology. 2014;121(3):785–796.
   PubMed Web of Science ®Google Scholar
• Lee RW, Dick AD. Treat early and embrace the evidence in favour of anti-TNF-alpha therapy for Behçet’s uveitis. Br J Ophthalmol. 2010;94(3):269–270.
   PubMed Web of Science ®Google Scholar
• Lightman S, Taylor SR, Bunce C, Longhurst H, Lynn W, Moots R, Stanford M, Tomkins-Netzer O, Yang D, Calder VL, Haskard DO. Pegylated interferon-α-2b reduces corticosteroid requirement in patients with Behçet’s disease with upregulation of circulating regulatory T cells and reduction of Th17. Ann Rheum Dis. 2015;74(6):1138–1144.
   PubMed Web of Science ®Google Scholar
• Deuter C, Stübiger N, Zierhut M. Interferon-α therapy in noninfectious uveitis. Dev Ophthalmol. 2012;51:90–97.
   PubMedGoogle Scholar
• Deuter CM, Kötter I, Wallace GR, Murray PI, Stübiger N, Zierhut M. Behçet’s disease: ocular effects and treatment. Prog Retin Eye Res. 2008;27(1):111–136.
   PubMed Web of Science ®Google Scholar
• Hatemi G, Silman A, Bang D, Bodaghi B, Chamberlain AM, Gul A, Houman MH, Kötter I, Olivieri I, Salvarani C, Sfikakis PP, Siva A, Stanford MR, Stübiger N, Yurdakul S, Yazici H, EULAR Expert Committee. EULAR recommendations for the management of Behçet disease. Ann Rheum Dis. 2008;67(12):1656–1662.
   PubMed Web of Science ®Google Scholar
• Kitaichi N, Miyazaki A, Iwata D, Ohno S, Stanford MR, Chams H. Ocular features of Behçet’s disease: An international collaborative study. Br J Ophthalmol. 2007;91(12):1579–1582.
   PubMed Web of Science ®Google Scholar
• Khairallah M, Accorinti M, Muccioli C, Kahloun R, Kempen JH. Epidemiology of Behçet disease. Ocul Immunol Inflamm. 2012;20(5):324–335.
   PubMed Web of Science ®Google Scholar
• Tugal-Tutkun I, Ozdal PC, Oray M, Onal S. Review for diagnostics of the year: Multimodal imaging in Behçet uveitis. Ocul Immunol Inflamm. 2017;25(1):7–19.
   PubMed Web of Science ®Google Scholar
• Moon SW, Kim BH, Park UC, Yu HG. Inter-observer variability in scoring ultra-wide-field fluorescein angiography in patients with Behçet retinal vasculitis. Ocul Immunol Inflamm. 2017;25(1):20–28.
   PubMed Web of Science ®Google Scholar
• Accorinti M, Pesci FR, Pirraglia MP, Abicca I, Pivetti-Pezzi P. Ocular Behçet’s disease: Changing patterns over time, complications and long-term visual prognosis. Ocul Immunol Inflamm. 2017;25(1):29–36.
   PubMed Web of Science ®Google Scholar
• Horie Y, Meguro A, Ohta T, Lee EB, Namba K, Mizuuchi K, Iwata D, Mizuki N, Ota M, Inoko H, Ishida S, Ohno S, Kitaichi N. HLA-B51 carriers are susceptible to ocular symptoms of Behçet disease and the association between the two becomes stronger towards the east along the Silk Road: A literature survey. Ocul Immunol Inflamm. 2017;25(1):37–40.
   PubMed Web of Science ®Google Scholar
• Yalcindag FN, Kiziltunc PB, Savku E. Evaluation of intraocular inflammation with laser flare photometry in Behçet uveitis. Ocul Immunol Inflamm. 2017;25(1):41–45.
   PubMed Web of Science ®Google Scholar
• Keino H, Okada AA, Watanabe T, Nakayama M, Nakamura T. Efficacy of infliximab for early remission induction in refractory uveoretinitis associated with Behçet disease: A 2-year follow-up study. Ocul Immunol Inflamm. 2017;25(1):46–51.
   PubMed Web of Science ®Google Scholar
• Takeuchi M, Karasawa Y, Harimoto K, Tanaka A, Shibata M, Sato T, Caspi RR, Ito M. Analysis of Th cell-related cytokine production in Behçet disease patients with uveitis before and after infliximab treatment. Ocul Immunol Inflamm. 2017;25(1):52–61.
   PubMed Web of Science ®Google Scholar
• Tugal-Tutkun I, Kadayifcilar S, Khairallah M, Lee SC, Ozdal P, Özyazgan Y, Song JH, Yu HG, Lehner V, de Cordoue A, Bernard O, Gül A. Safety and efficacy of gevokizumab in patients with Behçet’s disease uveitis: Results of an exploratory phase 2 study. Ocul Immunol Inflamm. 2017;25(1):62–70.
   Google Scholar
• Hasanreisoglu M, Cubuk MO, Ozdek S, Gurelik G, Aktas Z, Hasanreisoglu B. Interferon alpha-2a therapy in patients with refractory Behçet uveitis. Ocul Immunol Inflamm. 2017;25(1):71–75.
   PubMed Web of Science ®Google Scholar
• Diwo E, Gueudry J, Saadoun D, Weschler B, LeHoang P, Bodaghi B. Long-term efficacy of interferon in severe uveitis associated with Behçet disease. Ocul Immunol Inflamm. 2017;25(1):76–84.
   PubMed Web of Science ®Google Scholar
• Kim M, Kwon HJ, Choi EY, Kim SS, Koh HJ, Lee SC. Correlation between fluorescein angiographic findings and visual acuity in Behçet retinal vasculitis. Yonsei Med J. 2015;56(4):1087–1096.
   PubMed Web of Science ®Google Scholar
• Takeuchi M, Hokama H, Tsukahara R, Kezuka T, Goto H, Sakai J, Usui M. Risk and prognostic factors of poor visual outcome in Behçet’s disease with ocular involvement. Graefes Arch Clin Exp Ophthalmol. 2005;243(11):1147–1152.
   PubMed Web of Science ®Google Scholar
• Mesquida M, Llorenç V, Fontenla JR, Navarro MJ, Adán A. Use of ultra-wide-field retinal imaging in the management of active Behçet retinal vasculitis. Retina. 2014;34(10):2121–2127.
   PubMed Web of Science ®Google Scholar
• Leder HA, Campbell JP, Sepah YJ, Gan T, Dunn JP, Hatef E, Cho B, Ibrahim M, Bittencourt M, Channa R, Do DV, Nguyen QD. Ultra-wide-field retinal imaging in the management of non-infectious retinal vasculitis. J Ophthalmic Inflamm Infect. 2013;3(1):30–35.
   PubMedGoogle Scholar
• Oray M, Onal S, Bayraktar S, Izgi B, Tugal-Tutkun I. Nonglaucomatous localized retinal nerve fiber layer defects in Behçet uveitis. Am J Ophthalmol. 2015;159(3):475–481.
   PubMed Web of Science ®Google Scholar
• Khairallah M, Abroug N, Khochtali S, Mahmoud A, Jelliti B, Coscas G, Lupidi M, Kahloun R, Ben Yahia S. Optical coherence tomography angiography in patients with Behçet uveitis. Retina. 2016 Dec 20. doi: 10.1097/IAE.0000000000001418. [Epub ahead of print]
   PubMedGoogle Scholar
• Tugal-Tutkun I, Herbort CP, Khairallah M, Angiography Scoring for Uveitis Working Group (ASUWOG). Scoring of dual fluorescein and ICG angiographic signs for the grading of posterior segment inflammation (dual fluorescein and ICG angiogrphic scoring system for uveitis). Int Ophthalmol. 2010;30:539–552.
   PubMedGoogle Scholar
• Tugal-Tutkun I, Herbort CP, Khairallah M, Mantovani A. Interobserver agreement in scoring of dual fluorescein and ICG inflammatory angiographic signs for the grading of posterior segment inflammation. Ocul Immunol Inflamm. 2010;18:385–389.
   PubMed Web of Science ®Google Scholar
• Yu HG, Kim MJ, Oh FS. Fluorescein angiography and visual acuity in active uveitis with Behçet disease. Ocul Immunol Inflamm. 2009;17:41–46.
   PubMed Web of Science ®Google Scholar
• Ohno S, Ohguchi M, Hirose S, Matsuda H, Wakisaka A, Aizawa M. Close association of HLA-Bw51 with Behçet’s disease. Arch Ophthalmol. 1982;100:1455–1458.
   PubMed Web of Science ®Google Scholar
• Zamecki KJ, Jabs DA. HLA typing in uveitis: use and misuse. Am J Ophthalmol. 2010;149(2):189–193.
   PubMed Web of Science ®Google Scholar
• Tugal-Tutkun I, Cingu K, Kir N, Yeniad B, Urgancioglu M, Gül A. Use of laser flare-cell photometry to quantify intraocular inflammation in patients with Behçet uveitis. Graefes Arch Clin Exp Ophthalmol. 2008;246:1169–1177.
   PubMed Web of Science ®Google Scholar
• Yang P, Fang W, Huang X, Zhou H, Wang L, Jiang B. Alterations of aqueous flare and cells detected by laser flare-cell photometry in patients with Behçet’s disease. Int Ophthalmol. 2010;30:485–489.
   PubMedGoogle Scholar
• Gül A, Tugal-Tutkun I, Dinarello CA, Reznikov L, Esen BA, Mirza A, Scannon P, Solinger A. Interleukin-1beta regulating antibody XOMA 052 (gevokizumab) in the treatment of acute exacerbations of resistant uveitis of Behçet’s disease: an open-label pilot study. Ann Rheum Dis. 2012;71:563–566.
   PubMed Web of Science ®Google Scholar
• http://investors.xoma.com/releasedetail.cfm?ReleaseID=923200
   Google Scholar
• Deuter CM, Zierhut M, Möhle A, Vonthein R, Stöbiger N, Kötter I. Long-term remission after cessation of interferon-α treatment in patients with severe uveitis due to Behçet’s disease. Arthritis Rheum. 2010;62(9):2796–2805.
   PubMed Web of Science ®Google Scholar
• Shimizu T, Ehrlich GE, Inaba G, Hayashi K. Behçet’s disease. Sem Arthr Rheum. 1979;8:223–260.
   PubMed Web of Science ®Google Scholar